From: Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer
Univariate | Multivariatea | Multivariateb | ||||
---|---|---|---|---|---|---|
HR (95 % CI) | p | HR (95 % CI) | p | HR (95 % CI) | p | |
Gender | 0.316 | 0.968 | 0.704 | |||
Male | 1 | 1 | 1 | |||
Female | 0.7 (0.3–1.5) | 1.1 (0.4–2.5) | 0.8 (0.3–2.07) | |||
Histological grade | 0.031 | 0.563 | 0.697 | |||
Grade I-II | 1 | 1 | 1 | |||
Grade III | 2.2 (1.08–4.5) | 1.2 (0.6–2.6) | 1.2 (0.6–2.4) | |||
Cyr-61 expression | < 0.001 | 0.008 | - | |||
Low | 1 | 1 | ||||
High | 6.9 (2.6–18.04) | 4.1 (1.5–11.6) | ||||
COX-2 expression | < 0.001 | 0.039 | - | |||
Low | 1 | 1 | ||||
High | 5.6 (2.4–13.03) | 2.9 (1.06–7. 8) | ||||
Combined expression of Cyr-61 and COX-2 | 0.001 | - | 0.003 | |||
Both low | 1 | 1 | ||||
One low | 18.2 (2.3–142.7) | 0.006 | 17.9 (2.2–143.3) | 0.006 | ||
Both high | 34.8 (4.6–262.4) | 0.001 | 31.8 (4.09–246.8) | 0.001 |